BioWorld

Aug. 29, 2003

View Archived Issues

Amgen, Genentech Legal War Ends With Payout Settlement

Exploring Brain Neurons In Rats, Fish Rebuts Dogma That Memory Molecules Consolidate Only Once

As IPO Market Improves, Aderis Tries Again, Now Seeking $75M

Holiday notice

Berlex Planning Phase III Study Of Leukine In Crohn's Patients

Other News To Note

Corrections

Myogen Raises $40M Privately, Then Registers For $70M IPO

Falling in step with others in the industry, Myogen Inc. Thursday afternoon said it registered for an initial public offering, estimating it would raise $75 million. (BioWorld Today) Read More

Today's news in brief

BioWorld

BioWorld briefs for Jan 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 13, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld MedTech

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...